• Skip to primary navigation
  • Skip to main content
  • Skip to footer

HepVu

HepVu

An estimated 3.5 million people in the U.S. are living with chronic Hepatitis C infection.

  • INTERACTIVE MAP
  • Location Profiles
  • Find Services
  • News & Updates
  • Events
  • Tools & Resources
Home Events Webinar: Research of Hepatitis B Virus and Related Disease in the United States

Webinar: Research of Hepatitis B Virus and Related Disease in the United States

January 26, 2023

The 11th webinar in the “Moving for Hepatitis Discovery to Elimination” series is hosted by National Institute of Diabetes and Digestive Diseases (NIDDK).

The Hepatitis B Research Network (HBRN) was a multicenter network established by NIDDK to investigate the etiology and progression of hepatitis B (HBV) and to test the safety and efficacy of current therapies. Join this webinar to learn of highlights from the research conducted by the Network.

Presenters:

     Anna Lok, University of Michigan | Chronic hepatitis B in the US: clinical features, natural history and outcomes

     Will Lee, University of Texas Southwestern | Acute hepatitis B: clinical features of 60 US Cases 

     Norah Terrault, University of Southern California | Treatment Strategies to Increase HBsAg Loss: Outcomes from the HBRN Immune Active Trial

Round table discussion:

  • Patrizia Farci, NIAID/NIH
  • Paul Skip Hayashi, FDA
  • Brian McMahon, US CDC

Where: Virtual

When: January 25, 2023 at 12:00pm ET

How to Attend: Register here

Sign up for HepVu updates.

Footer

AIDSVu HepVu

HepVu is presented by Emory University’s Rollins School of Public Health in partnership with Gilead Sciences, Inc.

  • About
  • FAQ
  • Data Methods
  • Datasets

Questions?
Info@HepVu.org

Media Inquiries
(202) 854-0480
Media@HepVu.org

Follow Us

  • Facebook
  • Twitter

© 2025 HepVu. All Rights Reserved.

  • Privacy Policy
  • Contact Us

Get HepVu in Your Inbox

Sign up to stay informed on new data, maps, expert Q&As, and infographics about Hepatitis C and opioids where you live.